Ahring, Philip K.
The University of Sydney · Filadelfia · Western Sydney University
4 papers on CoChatORCID 0000-0003-1807-3331
Most cited papers
- Verified
Gain-of-function and loss-of-function GABRB3 variants lead to distinct clinical phenotypes in patients with developmental and epileptic encephalopathies
Absalom, N. L., Liao, V. W. Y., Johannesen, K. M. H., Gardella, E., Jacobs, J., Lesca, G., Gokce-Samar, Z., Arzimanoglou, A., Zeidler, S., Striano, P., et al. (2022) · Nature Communications
Epilepsy research and treatmentGenetics and Neurodevelopmental Disorders
Cited by 89
- Verified
In Vitro Pharmacological Characterization of a Novel Selective α7 Neuronal Nicotinic Acetylcholine Receptor Agonist ABT-107
Malysz, J., Anderson, D. J., Grønlien, J. H., Ji, J., Bunnelle, W. H., Håkerud, M., Thorin-Hagene, K., Ween, H., Helfrich, R., Hu, M., et al. (2010) · The Journal of Pharmacology and Experimental Therapeutics
Nicotinic Acetylcholine Receptors StudyNeuroscience and Neuropharmacology Research
Cited by 50
- Verified
GABAA α5 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085
de Lucas, A. G., Ahring, P. K., Larsen, J. S., Rivera-Arconada, I., Lopez-Garcia, J. A., Mirza, N. R., & Munro, G. (2015) · Biochemical Pharmacology
Pain Mechanisms and TreatmentsNeuroscience and Neuropharmacology Research
Cited by 32
- Verified
Distinct neurodevelopmental and epileptic phenotypes associated with gain- and loss-of-function GABRB2 variants
Mohammadi, N. A., Ahring, P. K., Yu Liao, V. W., Chua, H. C., Ortiz de la Rosa, S., Johannesen, K. M., Michaeli-Yossef, Y., Vincent-Devulder, A., Meridda, C., Bruel, A.-L., et al. (2024) · eBioMedicine
Epilepsy research and treatmentGenetics and Neurodevelopmental Disorders
Cited by 27
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free